Company: WELNF
Filing Date: 2025-11-17
Form Type: DEF 14A
Source: 0001104659-25-113213
Chunk: 60

Company: Integrated Wellness Acquisition Corp
Filing Date: 2025-11-17
Form: DEF 14A
Chunk 60
---
 significant risk that the Company might not, despite its best efforts, be able to complete an initial business
combination on or before the Termination Date. If that were to occur, the Company would be precluded from completing the Btab Business
Combination or another Business Combination and would be forced to liquidate even if the Company’s shareholders are otherwise in
favor of consummating such transaction.

As contemplated by the M&A,
the holders of Public Shares may elect to redeem all or a portion of their Public Shares in exchange for their pro rata portion of the
funds held in the Trust Account if the Extension Amendment is approved.

Any holder of Public Shares
will be entitled to demand that such holder’s shares be redeemed for a full pro rata portion of the amount then in the Trust
Account (which, for illustrative purposes, was approximately $15.15 million, or $12.78 per share, as of November 3, 2025). The
closing price of the Company’s Class A ordinary shares on OTC Pink Limited Market (“OTC Markets”) on November
3, 2025 was $12.55 per share. Accordingly, if the market price were to remain the same until the date of the Meeting, exercising redemption
rights would result in a public shareholder receiving $0.23 more for each share than if such shareholder sold the shares in the open market.
The Company cannot assure shareholders that they will be able to sell their public shares in the open market, even if the market price
per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such shareholders
wish to sell their public shares.

You are not being asked to vote on the Business Combination at the Meeting. The vote by the Company shareholders on the Business Combination will occur at the separate Business Combination Meeting of the Company shareholders and the solicitation of proxies from the Company shareholders in connection with such separate Business Combination Meeting, and the related right of the Company shareholders to redeem in connection with the Business Combination (which is a separate right to redeem in addition to the right to redeem in connection with the M&A Amendment Proposals), is the subject of a separate proxy statement/prospectus. If you want to ensure your Public Shares are redeemed in the event the M&A Amendments are approved at the Meeting, you should elect to “redeem” your Public Shares in connection with the Meeting.

Reasons for the Proposed Extension Amendment

The M&A currently provides
that the Company has until December